Search results
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Colorado Springs Gazette· 3 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows By Reuters
Investing.com· 3 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Reuters· 3 days agoAbout one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight...
Is it OK to stop using obesity drugs?
The Columbian· 6 days agoMillions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if...
‘Magic Pill’ Review: Ozempic and the Hunger for Less
The Wall Street Journal· 4 days agoHari isn’t sure whether this dramatic shift—in both consumption habits and cultural norms—is an unambiguously good thing. In “Magic Pill,” he skillfully...
1 in 8 Americans have taken drugs like Ozempic — but mostly not for weight loss
Quartz· 3 days agoA growing number of Americans have taken GLP-1 drugs, like Ozempic and Wegovy. A majority (62%) of...
1 in 8 adults in the US has taken Ozempic or another GLP-1 drug, KFF survey finds
CNN.com· 3 days agoThe US Food and Drug Administration has reported shortages of the GLP-1 medications Ozempic, Wegovy...
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 5 days agoHowever, the real turning point came about two years ago when Novo Nordisk’s semaglutide (marketed...
Oprah Winfrey, 70, Says She Regrets Contributing To 'Diet Culture'
Women's Health via Yahoo News· 3 days agoTaking a weight-loss medication silenced Oprah's 'food noise' During the primetime special, experts...
Breaking Down Japan's Food Culture
Time Magazine· 4 days agoIn March 2023, the Japanese medical authorities announced that the new weight loss drug Wegovy—which was in staggering demand across the world, causing...
